GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3000
-0.0018 (-0.60%)
At close: Aug 28, 2026, 4:00 PM EDT
0.308496
+0.0085 (2.83%)
After-hours: Aug 28, 2026, 7:05 PM EDT
GT Biopharma Employees
GT Biopharma had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$11,380,000
Market Cap
13.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 1 | 0 | - | 1 | 0 |
| Dec 31, 2024 | 1 | -1 | -50.00% | 1 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | -6 | -75.00% | 2 | 0 |
| Dec 31, 2021 | 8 | 5 | 166.67% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| BioLineRx | 24 |
| PDS Biotechnology | 21 |
| SeaStar Medical Holding | 18 |
| Moleculin Biotech | 17 |
| AEON Biopharma | 8 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
GTBP News
- 12 days ago - GT Biopharma Slides: Corporate presentation - Filings
- 16 days ago - GT Biopharma Reports Second Quarter 2026 Financial Results - GlobeNewsWire
- 16 days ago - GT Biopharma Quarterly report: Q2 2026 - Filings
- 16 days ago - GT Biopharma Earnings release: Q2 2026 - Filings
- 2 months ago - GT Biopharma Proxy statement: Proxy filing - Filings
- 2 months ago - GT Biopharma Proxy statement: Proxy filing - Filings
- 2 months ago - Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet - GlobeNewsWire
- 3 months ago - GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives - GlobeNewsWire